Combined polychemotherapy and radiotherapy in advanced inoperable squamous cell carcinoma of the head and neck
- 1 November 1985
- journal article
- Published by Wiley in Head & Neck Surgery
- Vol. 8 (2), 74-77
- https://doi.org/10.1002/hed.2890080203
Abstract
Between August 1979 and August 1984, 46 untreated, inoperable patients with advanced squamous cell carcinoma of the head and neck were submitted to a combined modality of treatment based on four courses of polychemotherapy (vincristine, bleomycin, and methotrexate), rotated with three courses of radiotherapy, 20 Gy each. Forty‐six patients entered the study: 45 were evaluable for their response to the treatment and 46 for toxicity effects. We observed 26 complete responses (57.7%) and 14 partial responses (31.1%); overall actuarial survival was 28% at 55 months. Mucositis occurred in 11 patients, 3 patients suffered from nausea and vomiting, 2 patients developed fever, and 1 had a platelet count of 50,000/mm3. One toxic death occurred: one patient developed an acute renal failure related to Methotrexate.Keywords
This publication has 9 references indexed in Scilit:
- Adjuvant chemotherapy with Cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neckCancer, 1983
- Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynxCancer, 1983
- Toxicity and response criteria of the Eastern Cooperative Oncology GroupAmerican Journal of Clinical Oncology, 1982
- Long-term results of VBM and radiotherapy in advanced head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Failure of effective initial chemotherapy to modify the course of stage IV (MO) squamous cancer of the head and neckCancer, 1982
- Chemotherapy for head and neck cancer relapsing after radiotherapyCancer, 1981
- Synchronous VBM and radiotherapy in the treatment of squamous cell carcinoma of the head and neckClinical Otolaryngology, 1977